Summary Background/Purpose Malignant pleural effusion is a frequent situation in
pulmonary medicine. However, it is sometimes difficult to recognize the underlying etiology …

Malignant pleural mesothelioma (MPM) is a rare tumour due to occupational asbestos
exposure. The incidence of MPM will continue to increase until 2020-2030. The incidence …

Context.—Pleural pathology has been dominated by discussions relating to the diagnosis,
prognosis, etiology, and management of malignant mesothelioma. However, there exists a …

Malignant pleural mesothelioma (MPM), an asbestos-induced tumor, represents significant
diagnostic challenges for pathologists. Its histological diagnosis is stepwise and should be …

Primary and metastatic pleural neoplasms, and non‐neoplastic pleural diseases, can have
similar clinical, radiographic and gross features. However, treatments and prognoses of …

Objective.—We address the current classifications and new changes regarding uncommon
primary pleural tumors. Primary pleural tumors are divided according to their behavior and …

In contrast to primary lung neoplasms, primary pleural neoplasms are uncommon. Pleural
neoplasms may be difficult to diagnose and must be distinguished from metastatic …

Introduction Malignant pleural mesothelioma (MPM) is a rare malignancy with a poor
prognosis. While treatment with a platinum-based chemotherapy is the standard of care …

Malignant pleural mesothelioma (MPM) is a rare asbestos related cancer, aggressive and
unresponsive to therapies. Histological examination of pleural lesions is the gold standard of …

Malignant mesothelioma originates from the cells in the serosal lining that surrounds the
body cavities. Of all mesotheliomas, approximately 85% arise from the pleura, approximately …